Wyle Solomon

Wyle Solomon joined Nordic Biotech June 2007 to focus on the investment process and post-investment follow-up.
He has an extensive experience in pharmaceutical development, regulatory affairs and business development obtained through leadership positions at large, mid-sized, and start-up pharmaceutical companies.
Mr Solomon was formerly employed by Mylan Laboratories where he initially directed the regulatory affairs function for Mylan Technologies, a specialty pharmaceutical division located in Vermont.
Concurrent to completing his MBA in 2006, he moved into Commercial and Business Development for Mylan Technologies where he was responsible for identifying and analyzing market and project opportunities and the development and maintenance of alliances.
Wyle Solomon previously headed the regulatory affairs and pharmaceutical development functions at Achillion Pharmaceuticals in Connecticut, and held positions of increasing responsibility at Bristol-Myers Squibb in New Jersey, as a scientist in oncology drug discovery and in regulatory affairs.
Mr Solomon holds an MSc from Temple University School of Pharmacy in Pennsylvania and an MBA from McGill University School of Management in Montreal.